Explores diabetes technology integration in real-world care, suggesting enhanced patient outcomes.
The 2026 American Diabetes Association (ADA) Standards of Care position diabetes technologies as integral components of routine diabetes management rather than optional adjuncts, reflecting a shift towards broader eligibility, earlier initiation and sustained access across care settings. 1 Across device categories, the guidance emphasises individualised, patient-centred selection, with technology choice informed by personal circumstances, preferences and capabilities and caregiver involvement where relevant.1
No takes yet. Share an insight, caveat, or question.
Saybani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: